T1	Participants 37 97	patients with chronic myeloid leukemia in the chronic phase:
T2	Participants 233 300	patients with chronic myeloid leukemia treated by allogeneic marrow
T3	Participants 317 344	while in the chronic phase.
T4	Participants 566 586	Fifty-seven patients